ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 445 • 2019 ACR/ARP Annual Meeting

    What Is the Effect of Statins on the Risk of Rheumatoid Arthritis? Results of a Systematic Review and Meta-Analysis

    Elena Myasoedova1, Paras Karmacharya 1, Ali Duarte Garcia 1, John Davis 1, M.Hassan Murad 1 and Cynthia Crowson 2, 1Mayo Clinic, Rochester, MN, 2Mayo Clinic Rochester, Rochester

    Background/Purpose: The anti-inflammatory and immune-modulating effects of statins suggest that these drugs may influence the risk of developing autoimmune diseases, such as rheumatoid arthritis (RA). …
  • Abstract Number: 446 • 2019 ACR/ARP Annual Meeting

    High MDHAQ/RAPID3 (Multidimensional Health Assessment Questionnaire/Routine Assessment of Patient Index Data) Scores in RA Patients Who Have Depression According to a Screening Questionnaire

    Rosa Morlà1, Mariam Riad 2, Raul Castellanos-Moreira 3, Virginia Ruiz-Esquide 4, Raimon Sanmarti 5, Jose Gomez-Puerta 6, Theodore Pincus 2 and Isabel Castrejon 2, 1Rheumatology Unit, Xarxa Sanitaria Santa Tecla, Tarragona. Rheumatology, Fundacio Clinic, Barcelona, Barcelona, Spain, 2Division of Rheumatology, Rush University Medical Center, Chicago, IL, 3Rheumatology Department. Hospital Clínic Barcelona, Barcelona, Catalonia, Spain, 4Department of Rheumatology, Hospital Clínic, Barcelona, Barcelona, Catalonia, Spain, 5Department of Rheumatology, Hospital Clínic, Barcelona, Barcelona, Spain, 6Servei de Rheumatologia, Hospital Clinic Universtari, Barcelona, Barcelona, Catalonia, Spain

    Background/Purpose: Depression in rheumatoid arthritis (RA) patients may be pre-existent, amplified, or may develop after the onset of RA1. The Patient Health Questionnaire (PHQ9) is…
  • Abstract Number: 447 • 2019 ACR/ARP Annual Meeting

    Nail Abnormalities in a Cohort of Rheumatoid Arthritis Patients: Repetitive Trauma-Related Findings in Toenails Are Associated with Radiographic Damage

    Virginia Pascual-Ramos1, Silvia Méndez-Flores 1, Judith Domínguez-Cherit 1, Ana Gabriela Sánchez-Cárdenas 1, Ana Barrera-Vargas 2, Javier Merayo-Chalico 1 and Irazú Contreras-Yáñez 1, 1Instituto Nacional de Ciencias Médicas y Nutrición "Salvador Zubirán", Mexico City, Distrito Federal, Mexico, 2Instituto Nacional de Ciencias Médicas y Nutrición "Salvador Zubirán", Mexico City, Mexico

    Background/Purpose: Different dermatological changes and nail abnormalities have been reported in rheumatoid arthritis (RA) patients, some of which are specifically associated with the disease, while…
  • Abstract Number: 448 • 2019 ACR/ARP Annual Meeting

    Central Sensitization in Patients with Rheumatoid Arthritis Using the Central Sensitization Inventory

    Kentaro Noda1, Moe Saitou 1, Taro Ukichi 1, Yohsuke Oto 1, Ken Yoshida 1 and Daitaro Kurosaka 1, 1The Jikei University School of Medicine, Tokyo, Japan

    Background/Purpose: Pain of rheumatoid arthritis (RA) is thought to be nociceptive. However, recent studies indicate that RA pain also includes the mechanism of central sensitization…
  • Abstract Number: 449 • 2019 ACR/ARP Annual Meeting

    The Course of Disability Related to Function of the Upper Extremities in Early Rheumatoid Arthritis over 10 Years of Follow-up

    Maria Rydholm 1, Ingegerd Wikström 2, Maria Mellblom Bengtsson 1, Sofia Hagel 3, Lennart Jacobsson 4 and Carl Turesson2, 1Skåne University Hospital, Malmö, Sweden, 2Lund University, Malmö, Sweden, 3Skåne University Hospital, Lund, Sweden, 4Dept of Rheumatology and Inflammation Research, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Sweden,, Gothenburg, Sweden

    Background/Purpose: Patients with rheumatoid arthritis (RA) have increased disability, in particular due to involvement of the joints of the upper extremities. The Stanford Health Assessment…
  • Abstract Number: 450 • 2019 ACR/ARP Annual Meeting

    ACPA-positive versus ACPA-negative Rheumatoid Arthritis: Two Distinct Erosive Disease Entities on Radiography and Ultrasonography

    Julien Grosse1, Edem Allado 1, Camille Roux 1, Audrey Pierreisnard 2, Marion Couderc 3, Isabelle Clerc-Urmès 1, Thomas Remen 1, Eliane Albuisson 4, Marcelo De Carvalho 1, Isabelle Chary-Valckenaere 4 and Damien Loeuille 5, 1Centre Hospitalier Universitaire de Nancy, Nancy, France, 2APHP, Paris, France, 3CHU G.Montpied, Clermont Ferrand, France, 4Centre Hospitalier Universitaire de Nancy, VANDOEUVRE, France, 5Rheumatology, Nancy University Hospital and and UMR 7365 CNRS-UL IMoPA, Université de Lorraine, VANDOEUVRE, France

    Background/Purpose: Several studies have shown that ACPA-positive (ACPA+) patients were more likely to develop erosive disease on radiography (RX) than ACPA-negative (ACPA-) patients, but it…
  • Abstract Number: 451 • 2019 ACR/ARP Annual Meeting

    Persistent and Non-Articular Regional and Widespread Pain Are Common in Early Rheumatoid Arthritis, Impacting Remission Rates and Reflected in Patient Global Scores

    Vivian P. Bykerk1, Orit Schieir 2, Marie-France Valois 3, Gilles Boire 4, Glen Hazlewood 5, Louis Bessette 6, Carol Hitchon 7, Diane Tin 8, Carter Thorne 9, Edward Keystone 10, Janet Pope 11, Susan J. Bartlett 12 and Canadian Early Arthritis Cohort (CATCH) Investigators 13, 1Hospital for Special Surgery, New York, NY, 2University of Toronto Dalla Lana School of Public Health, Toronto, ON, Canada, 3McGill University, Montreal, Canada, 4Sherbrooke University, Sherbrooke, QC, Canada, 5University of Calgary, Calgary, AB, Canada, 6Laval University, Quebec City, QC, Canada, 7University of Manitoba, Winnipeg, Canada, 8Southlake Regional Health Centre, Newmarket, Canada, 9Southlake Regional Health Centre, Newmarket, ON, Canada, 10Mount Sinai Hospital and University of Toronto, Toronto, ON, Canada, 11Western University, London, ON, Canada, 12McGill University, Montreal, QC, Canada, 13Canadian Early Arthritis Cohort (CATCH) Study, Toronto, Canada

    Background/Purpose: Persisting pain (NRS ≥4,) (PP) and non-articular pain (NAP), reduces quality of life for patients with RA. NAP is often attributed to fibromyalgia (FM),…
  • Abstract Number: 452 • 2019 ACR/ARP Annual Meeting

    Anti-citrullinated Vimentin Antibodies Are Associated to Early Deterioration of Cortical Bone and Volumetric Bone Mineral Density in Finger Joints in RA-at-risk Patients

    Georg Schett1, David Simon 2, Axel Hueber 2, Holger Bang 3, Jürgen Rech 4, Gerhard Kroenke 5 and Arnd Kleyer 6, 1Department of Internal Medicine 3, Friedrich Alexander University Erlangen-Nuremberg, Erlangen, Germany, 2Department of Internal Medicine 3, Friedrich-Alexander-University Erlangen-Nuremberg (FAU) and Universitätsklinikum Erlangen, Erlangen, Bayern, Germany, 3Orgentec Diagnostika, 55129 Mainz, Germany, Mainz, 4Department of Internal Medicine 3, Friedrich-Alexander-University Erlangen-Nuremberg (FAU) and Universitätsklinikum Erlangen, Erlangen, Germany, 5Department of Internal Medicine 3, Friedrich-Alexander-University Erlangen-Nuremberg (FAU) and Universitätsklinikum Erlangen, Erlangen, Austria, 6Department of Internal Medicine 3 – Rheumatology and Immunology, Friedrich-Alexander-University Erlangen-Nürnberg, University Hospital Erlangen, Erlangen, Germany, Erlangen, Germany

    Background/Purpose: Autoimmunity, characterized by the presence of anti-modified protein antibodies (AMPA), recognizing citrullinated, carbamylated or acetylated proteins, as well as rheumatoid factor (RF) precedes the…
  • Abstract Number: 453 • 2019 ACR/ARP Annual Meeting

    Including Pain, Fatigue and Functionality Regularly in the Assessment of Patients with Early Rheumatoid Arthritis Separately Adds to the Evaluation of Disease Status

    Sofia Pazmino1, Anikó Lovik 2, Annelies Boonen 3, Diederik De Cock 1, Veerle Stouten 1, Johan Joly 4, Kristien Van der Elst 5, Delphine Bertrand 1, Rene Westhovens 6 and Patrick Verschueren 5, 1KU Leuven, Leuven, Belgium, 2Leuven Biostatistics and Statistical Bioinformatics Center, KU Leuven, Leuven, Vlaams-Brabant, Belgium, 3Maastricht University Medical Center, Maastricht, Netherlands, 4University Hospitals Leuven, Leuven, Vlaams-Brabant, Belgium, 5University Hospital Leuven, Leuven, Belgium, 6University Hospitals, Leuven, Belgium

    Background/Purpose: Rheumatoid arthritis (RA) level of disease activity, cannot be evaluated by a single clinical or laboratory measurement. Hence, composite indices have been created via…
  • Abstract Number: 454 • 2019 ACR/ARP Annual Meeting

    Principal Component Analysis Identifies Unique Sub-Populations in Rheumatoid Arthritis Using a Combination of Serological Biomarkers: A Cross Sectional Study

    Jordan Van Dyk1, Bryan Heard 1 and Cheryl Barnabe 1, 1University of Calgary, Calgary, AB, Canada

    Background/Purpose: Determining the prognosis of rheumatoid arthritis (RA) could guide more precise treatment selection, optimizing outcomes while minimizing unnecessary therapeutic exposures. It is important that…
  • Abstract Number: 455 • 2019 ACR/ARP Annual Meeting

    Anti-Protein-Arginine Deiminase (PAD) 4 IgA Are Present in the Sera of Rheumatoid Arthritis Patients and Are Associated with Joint Erosion and Biological Treatment Use

    Laura Martinez-Prat1, Victor Manuel Martínez Taboada 2, Marcos Lopez-Hoyos 3 and Michael Mahler 4, 1Inova Diagnostics, Francisco de Vitoria University, San Diego, CA, 2Hospital Universitario Marqués de Valdecilla, Santander, Spain, 3Hospital Universitario Marqués de Valdecilla-IDIVAL, Santander, Cantabria, Spain, 4Inova Diagnostics, San Diego, CA

    Background/Purpose: Over the past years, novel biomarkers have been described in rheumatoid arthritis (RA) patients, including autoantibodies to the protein-arginine deiminase (PAD) enzymes. Anti-PAD4 IgG…
  • Abstract Number: 456 • 2019 ACR/ARP Annual Meeting

    Vitamin D Is Not Associated with Treatment Responses in Patients with Newly Diagnosed Rheumatoid Arthritis

    Juyeon Kang 1 and Chan-Bum Choi1, 1Hanyang University Hospital for Rheumatic Diseases, Seoul, Republic of Korea

    Background/Purpose: Vitamin D is known to have immunomodulatory properties and had shown a relationship with susceptibility and disease activity in rheumatoid arthritis (RA). We investigated…
  • Abstract Number: 457 • 2019 ACR/ARP Annual Meeting

    Serum Myostatin in Patients with Rheumatoid Arthritis and Its Correlations with Body Compositions and the Disease Activity

    Yoko Wada1, Masanori Sudo 2, Daisuke Kobayashi 2, Takeshi Kuroda 3 and Masaaki Nakano 4, 1Niigata Rinko Hospital, Niigata, Niigata, Japan, 2Division of Clinical Nephrology and Rheumatology, Niigata University, Niigata, Niigata, Japan, 3Health administration office, Niigata University, Niigata, Niigata, Japan, 4School of Health Sciences, Faculty of Medicine, Niigata University, Niigata, Niigata, Japan

    Background/Purpose: Altered body composition is a common feature of patients with rheumatoid arthritis (RA), up to two-thirds of affected patients showing loss of muscle mass…
  • Abstract Number: 458 • 2019 ACR/ARP Annual Meeting

    The Influence of Mediterranean Diet in Rheumatoid Arthritis: A Monocenter Cross-sectional Study

    Francesca Ingegnoli1, Tommaso Schioppo 1, Isabella Scotti 2, Giuseppe Marano 2, Patrizia Boracchi 2, Orazio De Lucia 3, Antonella Murgo 3 and Roberto Caporali 1, 1Division of Clinical Rheumatology, ASST Pini-CTO, Università degli Studi di Milano, Department of Clinical Sciences and Community Health, Milan, Italy, Milano, Italy, 2Università degli Studi di Milano, Milano, Italy, MILANO, Italy, 3Division of Clinical Rheumatology, ASST Pini-CTO, Milan, Italy, Milano, Italy

    Background/Purpose: Mediterranean diet (MD) is considered a well-balanced and potentially anti-inflammatory diet characterized by high consumption of olive oil, unrefined cereals, fresh or dried fruit…
  • Abstract Number: 459 • 2019 ACR/ARP Annual Meeting

    The Effects of Erythrocytes and Platelets on Disease Activity in Patients with RA – ANSWER Longitudinal Cohort Study –

    Akira Onishi1, Kengo Akashi 1, Sadao Jinno 2, Yonsu Son 3, Hideki Amuro 3, Toru Hirano 4, Yuichi Maeda 5, Motomu Hashimoto 6, Wataru Yamamoto 6, Kosaku Murakami 6, Ryota Hara 7, Masanori Katayama 8, Tohru Takeuchi 9, Takuya Kotani 9, Jun Saegusa 1 and Akio Morinobu 1, 1Department of Rheumatology and Clinical Immunology, Kobe University Graduate School of Medicine, Kobe, Japan, 2Department of Rheumatology and Clinical Immunology, Kobe University Graduate School of Medicine, Osaka, Japan, 3First Department of Internal Medicine, Kansai Medical University, Osaka, Japan, 4Department of Respiratory Medicine and Clinical Immunology, Graduate School of Medicine, Osaka University, Osaka, Japan, 5Department of Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine, Osaka, Japan, 6Department of Advanced Medicine for Rheumatic Diseases, Kyoto University Graduate School of Medicine, Kyoto, Japan, 7The Center for Rheumatic Disease, Department of Orthopedic Surgery, Nara Medical University, Nara, Japan, 8Department of Rheumatology, Osaka Red Cross Hospital, Osaka, Japan, 9Department of Internal Medicine IV, Osaka Medical College, Osaka, Japan

    Background/Purpose: Experimental models suggested both erythrocytes and platelets activated immune cells and enhanced inflammation in inflammatory arthritis. Although previous cross-sectional studies showed the form and…
  • « Previous Page
  • 1
  • …
  • 982
  • 983
  • 984
  • 985
  • 986
  • …
  • 2425
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology